Projects per year
Personal profile
Education/Academic qualification
Master
Fingerprint
Dive into the research topics where Elisa Ardizzoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
TB/NTM Research Cluster
de Jong, B., Sengstake, S., Rigouts, L., Tzfadia, O., Ardizzoni, E., Lynen, L., Decroo, T., Hasker, E., Van Rie, A. & Janssens, N.
Fonds voor Wetenschappelijk Onderzoek
1/01/22 → 31/12/26
Project: Research Project
-
EndTB-Q: EndTB-Q Output 5 testing new regimens to treat MDR-TB resistant to fluoroquinilones
de Jong, B., Ardizzoni, E. & Janssens, N.
1/07/20 → 30/04/24
Project: Research Project
-
-
End TB Clin.Trial Output 2
de Jong, B., Janssens, N. & Ardizzoni, E.
1/06/16 → 31/05/23
Project: Research Project
-
Improving detection of drug-resistant tuberculosis (TB by use of novel phenotypic and genotypic tests
Ardizzoni, E., de Jong, B., Rigouts, L. & Varraine, F.
1/01/13 → …
Project: PhD-project
Research output
- 14 A1: Web of Science-article
-
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
Antimycobacterial Susceptibility T, 2022, In : European Respiratory Journal. 59, 4, 11 p., 2200166.Research output: Contribution to journal › A1: Web of Science-article
-
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
Guglielmetti, L., Ardizzoni, E., Atger, M., Baudin, E., Berikova, E., Bonnet, M., Chang, E., Cloez, S., Coit, J. M., Cox, J., de Jong, B. C., Delifer, C., Do, J. M., Tozzi, D. D. S., Ducher, Ferlazzo, G., Gouillou, M., Khan, A., Khan, U., Lachenal, N. & 24 others, , 2021, In : Trials. 22, 1, 15 p., 651.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile4 Downloads (Pure) -
Thin-layer-agar-based direct phenotypic drug susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance otherwise missed by WHO-endorsed diagnostic tests
Ardizzoni, E., Ariza, E., Mulengwa, D., Mpala, Q., de la Tour, R., Maphalala, G., Varaine, F., Kerschberger, B., Graulus, P., Page, A. L., Niemann, S., Dreyer, A., Van Deun, A., Decroo, T., Rigouts, L. & de Jong, B. C., 2021, In : Antimicrobial Agents and Chemotherapy. 65, 6, 11 p., e02263-20.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile16 Downloads (Pure) -
Evaluation of OMNIgene Sputum and ethanol reagent for preservation of sputum prior to Xpert and culture testing in Uganda
Ardizzoni, E., Orikiriza, P., Ssuuna, C., Nyehangane, D., Gumsboga, M., Taremwa, I. M., Turyashemererwa, E., Mwanga-Amumpaire, J., Langendorf, C. & Bonnet, M., 2020, In : Journal of Clinical Microbiology. 58, 1, 11 p., e00810-19.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile3 Downloads (Pure) -
MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era
Beckert, P., Sanchez-Padilla, E., Merker, M., Dreyer, V., Kohl, T. A., Utpatel, C., Koeser, C. U., Barilar, I., Ismail, N., Omar, S. V., Klopper, M., Warren, R. M., Hoffmann, H., Maphalala, G., Ardizzoni, E., de Jong, B. C., Kerschberger, B., Schramm, B., Andres, S., Kranzer, K. & 3 others, , 2020, In : Genome Medicine. 12, 1, 11 p., 104.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile2 Downloads (Pure)